Expertise in
11
conditions

Ricard Ferrer

Barcelona, CT, ES 
Expertise in
11
conditions
Barcelona, CT, ES 

Overview

Ricard Ferrer practices practicing medicine in Barcelona, Spain.

Mr. Ferrer is highly rated in 11 conditions, according to our data. His clinical expertise encompasses COVID-19, Sepsis, Pneumonia, Lung Transplant, and Orchiectomy.

He is actively involved in clinical research, co-authoring 344 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Barcelona, CT, Spain
Other Locations
Cerdanyola Del Valles, CT, Spain
Spain
Madrid, MD, Spain
Bellaterra, CT, Spain
Terrassa, CT, Spain
Hospital Universitario Dr. Peset, 90, Valencia, VC, Spain
Sabadell, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2, Multi-Center, Randomized, Placebo-Controlled, Dose-Finding Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
A Phase 2, Multi-Center, Randomized, Placebo-Controlled, Dose-Finding Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Other, Drug
Study Drug: Allocetra-OTS
Study Phase: Phase 2
A Prospective, Double-blind, Randomized, Parallel, Placebo-controlled Pilot Clinical Trial for the Evaluation of the Efficacy and Safety of Two Doses of WJ-MSC in Patients With Acute Respiratory Distress Syndrome Secondary to Infection by COVID-19
A Prospective, Double-blind, Randomized, Parallel, Placebo-controlled Pilot Clinical Trial for the Evaluation of the Efficacy and Safety of Two Doses of WJ-MSC in Patients With Acute Respiratory Distress Syndrome Secondary to Infection by COVID-19
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Other, Drug
Study Drug: XCEL-UMC-BETA
Study Phase: Phase 1/Phase 2
Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Randomized, Sham-Controlled Study
Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Randomized, Sham-Controlled Study
Enrollment Status: Withdrawn
Publish Date: October 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Biological, Other
Study Drug: Cx611
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

344 Total Publications

International multidisciplinary consensus statement on sepsis code guidelines: A Delphi approach.
International multidisciplinary consensus statement on sepsis code guidelines: A Delphi approach.
Journal: Journal of internal medicine
Published: August 13, 2026

Frequently Asked Questions about Ricard Ferrer

Is Ricard Ferrer a top-rated expert for COVID-19?

MediFind is an objective health platform that identifies experts based on real-world data. Ricard Ferrer is classified as an Elite expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ricard Ferrer participate in research or clinical trials?

Yes. Ricard Ferrer has published 344 articles and abstracts on conditions like COVID-19. You can view a list of Ricard Ferrer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ferrer's expertise for a condition
ConditionClose
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile